Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of comparing outcomes of patients
treated de novo with immunosuppressive therapy (IST) versus matched unrelated donor (MUD)
hematopoietic stem cell transplant (HSCT) for pediatric acquired severe aplastic anemia.